Abstract: The invention generally relates in part to methods of effecting weight loss and/or improving glucose tolerance in a patient in need thereof, comprising administering a MetAP2 inhibitor.
Type:
Grant
Filed:
December 17, 2014
Date of Patent:
May 16, 2017
Assignees:
Zafgen, Inc., Vanderbilt University
Inventors:
Thomas E. Hughes, James E. Vath, Alan D. Cherrington
Abstract: Disclosed are improved optical detection systems and methods comprising multiplexed interferometric detection systems and methods for determining a characteristic property of a sample, together with various applications of the disclosed techniques.
Abstract: Compositions and methods for inhibiting thrombosis without compromising hemostasis are described. Compositions include anti-factor XI monoclonal antibodies (aXIMabs) capable of binding to an epitope on the heavy chain of human FXI, particularly the A3 domain of the heavy chain of human FXI. Compositions also include epitope-binding fragments, variants, and derivatives of the monoclonal antibodies, cell lines producing these antibody compositions, and isolated nucleic acid molecules encoding the amino acid sequences of the antibodies. The disclosure further includes pharmaceutical compositions comprising the disclosed anti-factor XI monoclonal antibodies, or epitope-binding fragments, variants, or derivatives thereof, in a pharmaceutically acceptable carrier.
Type:
Grant
Filed:
July 27, 2015
Date of Patent:
May 2, 2017
Assignees:
Oregon Health & Science University, Vanderbilt University
Inventors:
Andras Gruber, Erik I. Tucker, Stephen Raymond Hanson, David Gailani
Abstract: Disclosed herein are monoclonal antibodies specific for factor XI (fXI) that prevent activation of fXI by factor XIIa (fXIIa). The monoclonal antibodies are universal fXI antibodies, capable of binding all mammalian species tested. The anti-fXI monoclonal antibodies prolong clotting time in mammalian plasmas. Moreover, administration of the fXI monoclonal antibodies disclosed herein results in inhibition of thrombosis without altering hemostasis in animal models of thrombosis. Thus, provided herein are monoclonal antibodies specific for fXI that block activation of fXI by fXIIa, compositions and immunoconjugates comprising such antibodies and their methods of use.
Type:
Grant
Filed:
December 12, 2014
Date of Patent:
May 2, 2017
Assignees:
Oregon Health & Science University, Vanderbilt University
Inventors:
Andras Gruber, Erik I. Tucker, David Gailani
Abstract: In one aspect, the invention relates to substituted 5-aminothieno[2,3-c]pyridazine-6-carboxamide analogs, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M4 (mAChR M4); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Type:
Grant
Filed:
August 22, 2014
Date of Patent:
May 2, 2017
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Craig W. Lindsley, P. Jeffrey Conn, Michael R. Wood, Michael S. Poslusney, James C. Tarr, Bruce J. Melancon
Abstract: A normally closed valve includes a plurality of fluid channels in fluid communication with each other, defined in a flexible base such that when a fluid channel is compressed, a fluid flow through the fluid channel is occluded, otherwise, the fluid flow through the fluid channel is unoccluded; and means for selectively compressing or uncompressing a desired fluid channel.
Type:
Grant
Filed:
November 21, 2013
Date of Patent:
April 11, 2017
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Frank E. Block, III, Philip C. Samson, John P. Wikswo
Abstract: A solenoid valve including a spool received within a housing. The spool is configured to move to multiple positions within the housing. The housing includes supply ports, exhaust ports, and outlet ports. When the spool is in a specific location, two outlet ports are in fluid communication with each other.
Abstract: The present disclosure provides for rapid identification of mechanism of action (MOA) for drugs and toxins, and does so in a rapid (30 days or less) fashion. The methods use a combination of high throughput bioinformatics and pathway analysis that examine a wide variety of biological parametics.
Type:
Application
Filed:
September 22, 2016
Publication date:
March 23, 2017
Applicant:
Vanderbilt University
Inventors:
Richard CAPRIOLI, John WIKSWO, John MCLEAN, Eric SKAAR, Jeremy L. Norris
Abstract: A mechanism for implementing a delay in a directional control valve in the movement of a valve spool within a valve body from a first position of the spool to a second position of the spool.
Abstract: Provided are patterned nanoporous gold (“P-NPG”) films that may act as at least one of an effective and stable surface-enhanced Raman scattering (“SERS”) substrate. Methods of fabricating the P-NPG films using a low-cost stamping technique are also provided. The P-NPG films may provide uniform SERS signal intensity and SERS signal intensity enhancement by a factor of at least about 1×107 relative to the SERS signal intensity from a non-enhancing surface.
Type:
Grant
Filed:
September 20, 2011
Date of Patent:
March 14, 2017
Assignee:
Vanderbilt University
Inventors:
Sharon M. Weiss, Yang Jiao, Judson D. Ryckman, Peter N. Ciesielski, G. Kane Jennings
Abstract: In one aspect, the invention relates to substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M1 (mAChR M1); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Type:
Grant
Filed:
October 28, 2012
Date of Patent:
March 7, 2017
Assignee:
Vanderbilt University
Inventors:
Craig W. Lindsley, P. Jeffrey Conn, Michael R. Wood, Corey R. Hopkins, Bruce J. Melancon, Michael S. Poslusney, Darren W. Engers
Abstract: A method for automatic segmentation of intra-cochlear anatomy of a patient. The patient has an implanted ear and a normal contralateral ear. At least one computed tomography (CT) image is obtained to generate a first image corresponding to the normal contralateral ear and a second image corresponding to the implanted ear. Intra-cochlear surfaces of at least one first structure of interest (SOI) of the normal contralateral ear in the first image are segmented using at least one active shape model (ASM). Next, the segmented intra-cochlear surfaces in the first image is projected to the second image using a transformation function, thereby obtaining projected segmented intra-cochlear surfaces for the implanted ear in the second image.
Type:
Grant
Filed:
February 7, 2014
Date of Patent:
March 7, 2017
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Fitsum A. Reda, Jack H. Noble, Benoit Dawant, Robert F. Labadie
Abstract: In one aspect, the invention relates to chemical modulators of insect olfactory receptors. In particular, compounds and compositions are provided that can inhibit sensory (e.g., host targeting) functions in airborne insects such as mosquitos. Method of employing such agents, and articles incorporating the same, are also provided. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Type:
Grant
Filed:
April 25, 2012
Date of Patent:
February 28, 2017
Assignee:
Vanderbilt University
Inventors:
Laurence Zwiebel, Gregory M. Pask, David C. Rinker, Ian M. Romaine, Gary A. Sulikowski, Paul R. Reid, Alex G. Waterson, Kwangho Kim, Patrick L. Jones, Robert W. Taylor
Abstract: An NMR imaging system comprising a transceiver module configured to couple with a magnetic resonance transmitter coil, where the transceiver module includes a first transmitter channel and a pulse programmer configured to control the transceiver module, the transceiver module generating a precession and nutation for observing rotation at multiple intervals about the carrier (“PANORAMIC”) waveform, the PANORAMIC waveform configured to produce nuclear polarization. The PANORAMIC waveform may a single-banded PANORAMIC waveform or a multiple-banded PANORAMIC waveform. A method of NMR spectroscopy or imaging, the method comprising: determining for a nuclear spin rotation at least one frequency interval and at least one corresponding phase; creating a PANORAMIC waveform for the at least one frequency interval and the at least one corresponding phase; and applying the PANORAMIC waveform from an amplifier output to a probe input.
Abstract: Disclosed herein are crosslinked polycarbonates, composition thereof and methods thereof. The cross-linked polycarbonates can be prepared from allyl or epoxy polycarbonates. Described herein is the formation of functionalized poly(carbonate) particles with an established intermolecular cross-linking process. Six types of ‘nanosponges’ were prepared with the differentiation in crosslinking density and crosslinking chemistry. The intermolecular chain cross-linking process was investigated via the epoxide amine reaction and the thiol-ene click reaction.
Abstract: The present invention provides simple and inexpensive assays for the detection of virtually any analyte in any sample that is in liquid form or that can be solubilized. The assays utilize the fluid dynamics of drop evaporation whereby soluble materials, including analytes and particles binding thereto, are drawn to the edge of the drop and ultimately form a concentrated residual ring. The presence or absence of certain reagents can then be detected through a number of different approaches.
Type:
Grant
Filed:
October 20, 2010
Date of Patent:
February 21, 2017
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Frederick R. Haselton, Joshua Robert Trantum, David W. Wright
Abstract: Embodiments of the invention include substituted indole compounds and compositions thereof to inhibit protease activated receptor-4. Also described are methods of preparation of compositions and methods for treating diseases related to thrombotic disorders by administration of the composition.
Type:
Grant
Filed:
August 6, 2015
Date of Patent:
February 21, 2017
Assignee:
Vanderbilt University
Inventors:
Heidi E. Hamm, Shaun R. Stauffer, Craig W. Lindsley, Wandong Wen, Summer E. Young, Matthew T. Duvernay, Kayla J. Temple
Abstract: Provided are antibodies that selectively bind to and inhibit activation of coagulation factor XII. Methods of treatment employing these antibodies are described herein.
Type:
Grant
Filed:
December 6, 2013
Date of Patent:
February 21, 2017
Assignees:
VANDERBILT UNIVERSITY, ARONORA, INC., OREGON HEALTH & SCIENCE UNIVERSITY
Inventors:
Andras Gruber, David Gailani, Philberta Leung, Anton Matafonov
Abstract: One aspect of the invention provides a method for customizing cochlear implant stimulation of a living subject. The cochlear implant includes an electrode array having a plurality of electrodes implanted in a cochlea of the living subject. The method includes determining a position for each of the plurality of electrodes and spiral ganglion nerves that the electrode array stimulates, determining a geometric relationship between neural pathways within the cochlea and the electrode array implanted therein, and using one or more electrodes of the electrode array to stimulate a group of SG neural pathways of the cochlea based on the location of the one or more electrodes and their geometric relationship with the neural pathways.
Type:
Grant
Filed:
April 3, 2013
Date of Patent:
February 21, 2017
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Jack H. Noble, Rene H. Gifford, Robert F. Labadie, Benoit M. Dawant
Abstract: An exoskeleton for applying force to at least one lower limb of a user includes a control system with a sensor interface for sensor signals; a power interface for transmitting control signals to the powered joint; a processor coupled to the sensor and the power interfaces; and a computer-readable medium storing a computer program executable on the processor with code sections for: estimating a configuration of a body of the user with respect to a gravity vector based on the sensor signals; computing a control torque for the powered joint that compensates gravitational dynamics of the user based on the configuration; calculating a gravitational energy gradient for the powered joint; attenuating the control torque based on the gravitational energy gradient; computing a final control torque based on the attenuated control torque, and configuring the control signals based on the attenuated control torque.